Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
08 July 2021 | Story Rulanzen Martin | Photo Supplied
For Prof Anthea van Jaarsveld, the balance between science, theoretical and practical experience is important for a balanced industry.

Her unique approach to Drama and Theatre Arts makes Prof Anthea van Jaarsveld the most suitable person to take over the reins as Head of the UFS Department of Drama and Theatre Arts. Prof Van Jaarsveld was officially appointed as head of this special department this year. 

The Department of Drama at the UFS is one of the biggest in the country, and according to Prof Van Jaarsveld it is also the best, because the department produces some of the finest in the industry. Her main goal as head of department is to bring about a subtle change in emphasis that will ultimately make a real contribution to employability, a greater variety of job opportunities, and practice-orientated research. “My ultimate goal is therefore an approach within which academy and practice will find each other for the benefit of both,” says Prof Van Jaarsveld.

Science, theatre and drama collide 

Prof Van Jaarsveld has a scientific approach to drama and theatre arts. She never acted professionally. It is precisely from a scientific perspective that her knowledge of the theorising and contextualisation of drama text, theatre concepts, and the film industry is applied in order to maintain a balance in a profession where the emphasis on practical experience is overwhelming.  

She studied Drama at the UFS and was also employed as Drama teacher at Eunice Girls’ School. Following this, she started working as lecturer in the Department of Afrikaans and Dutch. “There I focused on the Drama genre in Afrikaans; therefore, I never actually left drama and theatre,” says Prof Van Jaarsveld. In 2018, she returned to the Department of Drama. 

Upon her return to the department where she started her studies, her aim is to ensure that the department again complies with the total package of the UFS and to make sure “that our students are prepared for a multifaceted and dynamic industry on a practical level”. 

Prof Van Jaarsveld took over from Prof Nico Luwes who retired in 2019. 

News Archive

Researchers receive study grant for research into Congo Fever
2015-03-10

UFS researchers will be contributing significantly to the search for a vaccine against the deadly tick-borne disease known as Congo Fever.

Prof Felicity Burt from the Department of Medical Microbiology and Virology was recently awarded a research grant by the National Health Laboratory Service (NHLS) to study candidate vaccines for Crimean-Congo heamorrhagic fever (CCHF) virus and other arboviruses.

Arboviruses are viruses transmitted by mosquitoes, ticks, or other arthropods.

Prof Burt is an internationally-recognised expert on the Crimean-Congo haemorrhagic fever (CCHF). The Crimean-Congo haemorrhagic fever (CCHF) virus is a tick-borne virus that is associated with severe haemorrhagic disease in South Africa and other parts of Africa, Asia, and eastern Europe. Her interests focus on medically significant viruses that are transmitted by ticks and mosquitoes. Her research group is involved in determining the immune responses that are induced by different viral proteins.

Crimean-Congo haemorrhagic fever (CCHF) virus, a tick- borne virus found in Africa, Asia, the Balkans, and eastern Europe, causes severe viral haemorrhagic fever outbreaks.

Although a number of tick species are capable of becoming infected with CCHF virus, ticks of the genus Hyalomma, commonly referred to in SA as the “bont-legged ticks”, are the principal vector. The ticks have distinctive brown and white bands on their legs.

In February 1981, the first case of CCHF was recognised in South Africa (SA). To date, there have been nearly 200 cases of CCHF infection in SA with a 20% fatality rate. The majority of cases occurring in SA were in patients from the Northern Cape and Free State provinces.

“The funding that has been awarded will be used to profile immune responses against CCHF viral proteins, and investigate mechanisms and strategies to enhance these immune responses. We hope that the study will contribute knowledge towards the development of a vaccine against this medically significant virus.”

For more information or enquiries contact news@ufs.ac.za.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept